创伤性脑损伤后浸润性抗炎单核细胞通过toll样受体4/干扰素依赖通路调节小胶质细胞活化
本文为小鼠实验研究,采用控制性皮质撞击TBI模型,设假手术野生型、TBI野生型、假手术野生型+C34、TBI野生型+C34四组,于伤后第1、7、28、35天分析。结果显示,C34抑制TLR4后急性炎症期浸润性抗炎单核细胞增多、干扰素调节因子7减少,慢性炎症期凋亡减少、M2小胶质细胞表达降低,神经认知结局改善。作者据此提出,TLR4抑制剂C34使浸润单核细胞向抗炎表型偏移,并认为M2小胶质细胞在TBI后慢性愈合阶段具有不利作用。
要点
- 研究使用小鼠控制性皮质撞击TBI模型,比较假手术野生型、TBI野生型、假手术野生型+C34、TBI野生型+C34四组。
- TLR4抑制剂C34使急性炎症期浸润性抗炎单核细胞增多、干扰素调节因子7减少。
- 慢性炎症期C34组凋亡减少、M2小胶质细胞表达降低,神经认知结局改善。
- 作者认为,M2小胶质细胞虽常被视为神经保护诱导因素,但在TBI后慢性愈合阶段表现出不利作用。
- 结果为动物实验,作者结论为TLR4抑制使浸润单核细胞向抗炎表型偏移并改善神经认知结局。
适用人群与场景
- 小鼠控制性皮质撞击TBI模型;结果于伤后第1、7、28、35天分析。
处置流程与药物剂量
- C34为新型药理性toll样受体4抑制剂,用于小鼠TBI模型;原文未给出剂量、给药途径、频次或疗程。
研究设计与关键结果
- 研究类型为小鼠实验研究,采用控制性皮质撞击模型,设假手术野生型、TBI野生型、假手术野生型+C34、TBI野生型+C34四组,于伤后第1、7、28、35天分析。
- 定量实时聚合酶链反应用于定量小胶质细胞活化、凋亡通路和1型干扰素通路相关基因表达;流式细胞术用于分离小胶质细胞和浸润单核细胞;脑损伤体积用磁共振成像评估;神经认知结局用Morris水迷宫测试评估。
- TLR4抑制导致TBI后神经后遗症改善,可能因为急性炎症期浸润性抗炎单核细胞增多和干扰素调节因子7减少,随后慢性炎症期凋亡减少和M2小胶质细胞表达降低。
- 作者结论:C34抑制TLR4使浸润单核细胞向抗炎表型偏移,导致神经认知结局增强;并认为M2小胶质细胞在TBI后慢性愈合阶段具有不利作用。
证据类型、等级与局限
- 证据类型:小鼠实验研究。
- 统计方法:Student t检验和单因素方差分析,p<0.05为差异有统计学意义。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出临床推荐;结果为小鼠TBI模型实验,作者认为TLR4抑制使浸润单核细胞向抗炎表型偏移并改善神经认知结局,且M2小胶质细胞在慢性愈合阶段可能有害。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury (TBI) is the leading cause of morbidity and mortality in the pediatric population. Microglia and infiltrating monocyte-derived macrophages are crucial immune cells that modulate the neuroinflammatory response following TBI. Using C34, a novel pharmacologic toll-like receptor 4 inhibitor, we investigated the intricate interactions between these cells in a murine TBI model.
METHODS: A murine controlled cortical impact model was used, and the results were analyzed on postinjury days 1, 7, 28, and 35. The experimental groups are as follows: (1) sham C57BL/6 wild-type (WT), (2) TBI WT, (3) sham WT + C34, and (4) TBI WT + C34. Quantitative real-time polymerase chain reaction was used to quantify gene expression associated with microglial activation, apoptotic pathways, and type 1 interferon pathway. Flow cytometry was used to isolate microglia and infiltrating monocytes. Brain lesion volumes were assessed using magnetic resonance imaging. Last, neurocognitive outcomes were evaluated using the Morris Water Maze test. Student's t test and one-way analysis of variance were used for statistical analysis with significance achieved when p < 0.05.
RESULTS: Toll-like receptor 4 inhibition leads to improved neurological sequela post-TBI, possibly because of an increase in infiltrating anti-inflammatory monocytes and a decrease in IFN regulatory factor 7 during acute inflammation, followed by a reduction in apoptosis and M2 microglial expression during chronic inflammation.
CONCLUSION: Toll-like receptor 4 inhibition with C34 skews infiltrating monocytes toward an anti-inflammatory phenotype, leading to enhanced neurocognitive outcomes. Moreover, although M2 microglia have been consistently shown as inducers of neuroprotection, our results clearly demonstrate their detrimental role during the chronic phases of healing post-TBI.
参考来源
- El Baassiri MG, Chun YH, Rahal SS, et al. Infiltrating anti-inflammatory monocytes modulate microglial activation through toll-like receptor 4/interferon-dependent pathways following traumatic brain injury. J Trauma Acute Care Surg. 2023. PMID: 36598757. doi:10.1097/TA.0000000000003858
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。